Moriarty John B Insider Trades

Insider Trading History

Track insider trading activity for Moriarty John B. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Avidity Biosciences
Avidity Biosciences RNA
Chief Legal Officer
Holding Value $612k 47,755 shares
Last Trade
Aug 04, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$81.3k 2,245 shares
$36.21
$12.81
Avidity Biosciences
Avidity Biosciences RNA
Chief Legal Officer
Holding Value $641k 50,000 shares
Last Trade
Jan 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.57M 50,000 shares
$31.42
$12.81
Avidity Biosciences
Avidity Biosciences RNA
Chief Legal Officer
Holding Value $2.05M 160,000 shares
Last Trade
Aug 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.13M 160,000 shares
$44.57
$12.81
Mirati Therapeutics
Mirati Therapeutics MRTX
Chief Legal Officer
Holding Value $4.21M 71,660 shares
Last Trade
Jan 23, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$9.15M 155,860 shares
$58.70
$58.70
Mirati Therapeutics
Mirati Therapeutics MRTX
Chief Legal Officer
Holding Value $4.21M 71,660 shares
Last Trade
Aug 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$825k 22,297 shares
$37.00
$58.70
Mirati Therapeutics
Mirati Therapeutics MRTX
Chief Legal Officer
Holding Value $2.9M 49,363 shares
Last Trade
Jun 23, 2023 Sale
$3.11M 83,525 shares
$37.23
$58.70
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Evp, Ch. Legal Officer & Sec.
Holding Value $1.58M 150,000 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$731k 150,000 shares
$4.87
$10.53
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Holding Value $1.75M 166,250 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.17M 166,250 shares
$7.02
$10.53
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Evp, Ch. Legal Officer & Sec.
Holding Value $1.7M 161,406 shares
Last Trade
Nov 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$10.53
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Evp, Ch. Legal Officer & Sec.
Holding Value $0 0 shares
Last Trade
Nov 18, 2020 Sale
No data
No data
$10.53
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
Evp, Ch. Legal Officer & Sec.
Holding Value $2.65M 252,060 shares
Last Trade
Sep 19, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$10.53
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
Evp, General Counsel
Holding Value $0 0 shares
Last Trade
Jul 02, 2020 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
No data
No data
$0.00
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
Evp, General Counsel
Holding Value $0 49,976 shares
Last Trade
Mar 02, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
Evp, General Counsel
Holding Value $0 49,976 shares
Last Trade
Mar 02, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
Evp, General Counsel
Holding Value $0 73,125 shares
Last Trade
Feb 24, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
Evp, General Counsel
Holding Value $0 53,184 shares
Last Trade
Feb 03, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
Evp, General Counsel
Holding Value $0 39,952 shares
Last Trade
Mar 04, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
EVP & General Counsel
Holding Value $13.8M 75,737 shares
Last Trade
Feb 08, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$389k 3,363 shares
$115.70
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
EVP & General Counsel
Holding Value $9.11M 49,911 shares
Last Trade
Feb 05, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$148k 1,261 shares
$117.26
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
EVP & General Counsel
Holding Value $8.15M 44,672 shares
Last Trade
Mar 01, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$37.4k 282 shares
$132.50
$182.50

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up